Anand PS, Kamath KP, Anil S. Role of dental plaque, saliva and periodontal disease in Helicobacter pylori infection. World J Gastroenterol 2014; 20(19): 5639-5653 [PMID: 24914323 DOI: 10.3748/wjg.v20.i19.5639]
Corresponding Author of This Article
Pradeep S Anand, MDS, Department of Periodontics, People’s College of Dental Sciences and Research Centre, Bhanpur Bypass Road, Bhanpur, Bhopal, Madhya Pradesh 462037, India. deepusanand@yahoo.co.in
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Topic Highlight
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Pradeep S Anand, Department of Periodontics, People’s College of Dental Sciences and Research Centre, Bhopal, Madhya Pradesh 462037, India
Kavitha P Kamath, Department of Oral Pathology, People’s Dental Academy, Bhopal, Madhya Pradesh 462037, India
Sukumaran Anil, Department of Periodontics and Community Dentistry, College of Dentistry, King Saud University, Riyadh 11545, Saudi Arabia
ORCID number: $[AuthorORCIDs]
Author contributions: Anand PS contributed to the conception and design of the paper and edited the final version of the article for approval; Anand PS, Kamath KP, and Anil S performed the literature search, reviewed the literature, and prepared the draft version; Anand PS and Kamath KP revised and edited the draft version for intellectual content.
Correspondence to: Pradeep S Anand, MDS, Department of Periodontics, People’s College of Dental Sciences and Research Centre, Bhanpur Bypass Road, Bhanpur, Bhopal, Madhya Pradesh 462037, India. deepusanand@yahoo.co.in
Telephone: +91-998-1511098 Fax: +91-755-4005315
Received: September 28, 2013 Revised: January 19, 2014 Accepted: March 6, 2014 Published online: May 21, 2014 Processing time: 232 Days and 9.5 Hours
Abstract
Helicobacter pylori (H. pylori) infection is one of the most common bacterial infections in humans. Although H. pylori may be detected in the stomach of approximately half of the world’s population, the mechanisms of transmission of the microorganism from individual to individual are not yet clear. Transmission of H. pylori could occur through iatrogenic, fecal-oral, and oral-oral routes, and through food and water. The microorganism may be transmitted orally and has been detected in dental plaque and saliva. However, the role of the oral cavity in the transmission and recurrence of H. pylori infection has been the subject of debate. A large number of studies investigating the role of oral hygiene and periodontal disease in H. pylori infection have varied significantly in terms of their methodology and sample population, resulting in a wide variation in the reported results. Nevertheless, recent studies have not only shown that the microorganism can be detected fairly consistently from the oral cavity but also demonstrated that the chances of recurrence of H. pylori infection is more likely among patients who harbor the organism in the oral cavity. Furthermore, initial results from clinical trials have shown that H. pylori-positive dyspeptic patients may benefit from periodontal therapy. This paper attempts to review the current body of evidence regarding the role of dental plaque, saliva, and periodontal disease in H. pylori infection.
Core tip:Helicobacter pylori (H. pylori) infection is one of the most common bacterial infections in humans. The mode of transmission of this bacterium has long puzzled researchers. Numerous studies have shown that this microorganism can be detected in dental plaque and saliva of human subjects, suggesting that the oral cavity may be an extra-gastric reservoir of H. pylori and play an important role in both transmission and recurrence. Recent data support this hypothesis and indicate that periodontal therapy may play a role in the management of H. pylori-associated gastric disease.
Citation: Anand PS, Kamath KP, Anil S. Role of dental plaque, saliva and periodontal disease in Helicobacter pylori infection. World J Gastroenterol 2014; 20(19): 5639-5653
Helicobacter pylori (H. pylori) is one of the most common bacterial infections in humans[1]. It is a gram negative, microaerophilic, rod-shaped bacterium that colonizes the gastric mucosa. Although its presence in the human stomach has been reported from all parts of the world, the prevalence of H. pylori infection is higher in developing countries than developed countries[2,3]. First reported in 1983[4], H. pylori (initially termed Campylobacter pyloridis) is an important human pathogen associated with the etiology of chronic gastritis, peptic ulcer, gastric cancer, and mucosa-associated lymphoid tissue lymphoma[2,5,6] and has been designated as a Group 1 Carcinogen by the International Agency for Research on Cancer of the World Health Organization (WHO)[6,7]. In addition to gastro-intestinal diseases, recent data seem to suggest a possible association of this microorganism with other conditions, such as recurrent aphthous stomatitis[8], anemia[9], altered serum levels of lipoproteins[10], and coronary atherosclerosis[11].
A limited number of anti-microbial agents are effective against H. pylori and therapeutic regimens to eradicate the microorganism usually consist of a combination of antibiotics, proton pump inhibitors, and gastroprotective drugs[12,13]. These therapeutic regimens, particularly the combination of two antibiotics and a proton pump inhibitor, can successfully eradicate the microorganism resulting in significant clinical improvement[14]. However, recurrence rates, particularly in developing countries, are high[15-17]. This high rate of recurrence led investigators to study the various possible routes of transmission of the microorganism. Although H. pylori may be detected in the stomach of approximately half of the world’s population, the mechanisms of transmission of the microorganism from individual to individual are not yet clear. The possible routes of transmission of H. pylori include iatrogenic, fecal-oral, oral-oral, and through food and water[2,18-21]. H. pylori exists in two different morphological forms, spiral and coccoid. The coccoid form is considered a degenerative or dead form of H. pylori, and its role in transmission of disease is negligible[22,23]. There is ongoing debate about its virulence and transformation[24]. Although the coccoid form of H. pylori is metabolically active, it cannot be cultured in vitro[2]. The organism has been reported to be present in soil samples in public playgrounds[25]. However, no extra-gastric reservoirs of H. pylori have been clearly demonstrated, and although organisms resembling H. pylori may be detected in other animals, none except non-human primates[26]and cats[27] harbor H. pylori. Infections by Helicobacter species (H. heilmannii and H. felis) have been reported in dogs[28,29] and cats[29].
Regarding the various possible routes of transmission of H. pylori, the microorganism may be transmitted orally and has been detected in dental plaque and saliva[30-32]. However, the question still persists as to whether the oral cavity is a major extra-gastric reservoir for H. pylori or harbors the organism only transiently. If the oral cavity, particularly the dental plaque, serves as an extra-gastric reservoir of H. pylori, it may have potentially serious implications regarding the treatment of H. pylori infection. This is on account of the fact that treatment of H. pylori infection usually involves administration of systemic antibiotics in combination with other drugs, and dental plaque, being a microbial biofilm, provides protection for the resident microorganisms from systemically administered anti-microbial agents. Despite the current treatment regimens that lead to successful management of H. pylori-positive chronic gastritis, the re-infection rate is relatively high[14,33]. One of the suggested mechanisms of re-infection is the possible re-colonization from dental plaque[34]. A few studies have also suggested that periodontal disease may also favor colonization of dental plaque by H. pylori[35]. This paper attempts to review the role of dental plaque, saliva, and periodontal disease in H. pylori infection.
PRESENCE OF H. PYLORI IN DENTAL PLAQUE
The prevalence of H. pylori in dental plaque has been studied by several investigators. A summary of studies reporting the presence of H. pylori in dental plaque of participants is shown in Table 1. The prevalence of reported presence of H. pylori in dental plaque in these various studies ranged from 0%-100%. This wide variation in results may be explained by several factors, such as characteristics of the sample population, differing sampling procedures, and differing methodologies used to detect the microorganism in dental plaque.
Table 1 Studies evaluating the presence of Helicobacter pylori in dental plaque.
Pakistan; 89 dyspeptic patients reporting for endoscopy
51.6% (n = 46) for both genes; 62.9% (n = 56) for 16srRNA; 61.7% (n = 55) for 860-bp DNA region; 73% (n = 65) if either of the 2 regions were considered
Brazil; 115 patients-36 with dyspepsia and periodontal disease, 31 with dyspepsia but no periodontal disease, 22 with neither dyspepsia nor periodontal disease, 26 with periodontal disease and without dyspepsia
Brazil; 99 adult patients who underwent upper gastro-intestinal endoscopy
72% (71) samples were positive for H. pylori. Overall, 63 (89%) of 71 positive dental plaque samples were positive for vacA and cagA. 58/71 (82%) were positive for cagA, while vacA genotypes had a prevalence ranging from 13%-59%
Brazil; 23 HIV seropositive individuals (13 who had chronic periodontitis and 10 who were periodontally healthy) and 31 HIV seronegative individuals (17 who had chronic periodontitis and 14 who were periodontally healthy)
Not specified; frequency of detection was significantly higher in chronic periodontitis groups compared with periodontally healthy groups
Brazil; 30 individuals who were H. pylori-positive with gastric disease (cases) and 32 individuals who were H. pylori-positive with no gastric disease (controls)
Overall-17.7% (n = 11). Among cases, DNA detected in 36.6% (11/30); control group-0%
India; 36 patients in 3 groups-group I, healthy subjects, group II, chronic periodontitis patients, group III, chronic periodontitis patients with type II diabetes mellitus
Overall-66.7% (n = 24); among group I-41.7% (n = 5), group II-75% (n = 9), group III-83.3% (n = 10)
The diagnostic tests employed by different investigators to detect the presence of the microorganism in dental plaque include urease tests, polymerase chain reaction (PCR) techniques, immunoassays, cytology, and culture. Generally, the prevalence rates reported in studies employing urease tests were higher than studies employing other techniques. Lowest rates of detection have been reported when microbial culture was used to detect the presence of H. pylori in dental plaque. The use of urease tests for the detection of H. pylori in dental plaque has been subject to controversy. Although urease tests are reasonably specific for detection of the microorganism in gastric biopsy specimens, investigators have doubted its reliability for detecting H. pylori in oral specimens[36,37]. This controversy results from the fact that although H. pylori is the only urease-positive microorganism known to reside in the stomach, many urease-positive bacterial species, such as Streptococcus species, Haemophilus species, and Actinomyces species, may be detected as part of the normal oral flora. However, it has been reported that only H. pylori produces large amounts of urease, such that a positive urease test can occur within 20 min, while other urease-producing microorganisms are not positive within one hour[38]. Moreover, Gürbüz et al[39] reported that the rapid urease test for detection of H. pylori in dental plaque has a sensitivity of 89.7% and diagnostic accuracy of 86.7%.
Almost all of the studies utilizing urease tests for detection of H. pylori in dental plaque were conducted among Asian populations. In studies utilizing urease tests, the reported prevalence of the microorganism in dental plaque generally ranged from 80%-100%, with only one study reporting a prevalence below 40%[40].
The PCR technique for detection of H. pylori provides the advantage of detecting the target DNA regardless of the viability of the bacteria and detecting even small numbers of the target species. PCR also provides the advantage of identifying specific genotypes of the microorganism. The results of studies utilizing PCR techniques have been very variable, with the reported prevalence ranging from 0%-100%. Generally, the initial studies[41-44] utilizing PCR reported very low prevalence rates, while the later studies reported higher prevalence rates[45,46].
Microbial culture of H. pylori permits anti-microbial susceptibility testing as well as detailed study of the isolates[2]. However, the reported rates of prevalence in studies in which microbial culture was employed to detect H. pylori in dental plaque was generally low, with only three studies reporting prevalence rates above 20%[47-49]. Moreover, in two of these three studies that reported higher prevalence rates[47,48], each of which had a reported sample size of 100, the prevalence was reported to be 48.3%, which could not be interpreted accurately because the percentage data in a sample size of 100 should have a whole number value rather than a fraction. Low rates of prevalence of H. pylori in dental plaque reported in studies which have used culture methods have been attributed to the existence of H. pylori in the metabolically active but unculturable coccoid form in the dental plaque. H. pylori in the dental plaque, being outside its normal habitat in the stomach, may respond to the altered environment by altering its morphology, metabolism, and growth behavior resulting in the formation of a viable but non-culturable coccoid form[50,51]. Other factors which account for the low rates of prevalence reported with culture methods include the fastidious nature of the microorganism, complex nature of the oral microflora, and inhibition of H. pylori by other oral microorganisms[37,52].
Although different rates of detection of H. pylori in the dental plaque have been reported by various investigators, data generated from these studies show that the microorganism can be reliably detected in plaque samples, especially when PCR techniques are employed. While some investigators have suggested that the occurrence of H. pylori in dental plaque is significant in terms of management of H. pylori-associated gastric disease[53], others have suggested that the microorganism is present only transiently in the oral cavity[54].
Dental plaque is a microbial biofilm that adheres tenaciously to teeth and other hard surfaces in the oral cavity, such as restorations. In this biofilm, microbial communities are embedded in an extracellular matrix composed of organic and inorganic materials of both host and microbial origin[55]. The microbial flora of dental plaque is very complex; more than 500 different species of bacteria have been detected in plaque samples[56]. These bacterial species inhabit the biofilm not at random as passive neighbors but interact with other bacterial species through specific interactions. These interactions, along with the biofilm structure, confer a large number of advantages to the resident bacterial species. One major advantage that biofilm bacteria enjoy is an increased resistance to host defense mechanisms and anti-microbial agents[55,57]. Thus, H. pylori present in the dental plaque, being biofilm-associated, are protected from systemic antibiotics administered for the management of gastric H. pylori infection. As a result, the microorganism may persist in the oral cavity even after successful eradication from the stomach and hence, the possibility exists that dental plaque-associated H. pylori may serve as a possible source of re-infection and re-colonization of the stomach.
PREVALENCE OF H. PYLORI IN SALIVA
Compared with studies on dental plaque, there are fewer reports on the prevalence of H. pylori detection in saliva. Table 2 shows a summary of studies reporting on detecting H. pylori in saliva. The majority of these studies utilized either PCR or culture methods. The detection rates in saliva were generally less than in dental plaque, with only few studies reporting detection rates of 50%[46,58-60]. The prevalence rates were even lower in studies in which culture was used for detecting H. pylori compared with studies using PCR techniques[30,44,61].
Table 2 Studies evaluating the presence of Helicobacter pylori in saliva.
Brazil; 30 individuals who were H. pylori positive with gastric disease (cases) and 32 individuals who were H. pylori positive with no gastric disease (controls)
Overall-25.8% (n = 16). Among cases, H. pylori DNA detected in 53.3% (16/30); in control group-0%
As mentioned previously, detection rates of H. pylori from saliva were less than that from dental plaque. This may be due to the fact that, while dental plaque, being a biofilm, allows the bacteria to adhere to solid surfaces, the constant flow of saliva may contribute to a reduction in bacterial load, making detection difficult[62]. As with dental plaque, investigators have differed in their opinions regarding the significance of detection of H. pylori in the saliva. The detection of H. pylori in saliva and dental plaque may precede or be independent of gastric infection[59,63]. It is not yet clear whether the presence of the microorganism in the oral cavity represents long-term colonization or whether its presence is transient due to either gastric reflux or because it is in route to the stomach. While some authors maintain that H. pylori may be a normal commensal organism in the oral cavity with no relation to gastric infection[58,61], others, based on detection of H. pylori from dental plaque and saliva of patients with and without H. pylori infection, have suggested that the oral cavity may be a permanent reservoir of the organism, acting both as source of re-infection and a route of transmission[59,62].
ASSOCIATION OF ORAL HYGIENE/PERIODONTAL STATUS WITH H. PYLORI INFECTION
Studies that evaluated the association between oral hygiene status and periodontal status with H. pylori infection are shown in Table 3. Considerable variability was observed in the methods used in these studies to evaluate oral hygiene status and periodontal status. While some of these studies evaluated the association of oral hygiene and periodontal status with gastric H. pylori infection, others evaluated the association of these oral health variables with the oral carriage of H. pylori. Few studies considered the presence of H. pylori in both the stomach and oral cavity. While the majority of the studies did not show an association between periodontal status and gastric H. pylori infection, a few studies showed an association between periodontal disease and gastric H. pylori infection[39,64-66]. An epidemiological study conducted in the USA based on the National Health and Nutritional Examination Survey III data showed that periodontal disease may be associated with H. pylori infection, as determined by serological tests[66]. A positive association between periodontal disease and oral carriage of H. pylori has been reported by a few investigators[35,39,64,67-73]. Regarding oral hygiene status, while the majority of the studies did not show an association between oral hygiene status and gastric or oral carriage of H. pylori, Gürbüz et al[39] reported a positive association between plaque scores and both gastric and oral H. pylori. Similar to these findings, Butt et al[74] reported a positive association between the amount of plaque and detection of H. pylori in the oral cavity, while Bali et al[65] have reported that poor oral hygiene was significantly associated with gastric H. pylori infection.
Table 3 Studies evaluating the association of oral hygiene status and gingival/periodontal status with Helicobacter pylori infection.
India; 36 patients in 3 groups-group I, healthy subjects, group II, chronic periodontitis patients, group III, chronic periodontitis patients with type II diabetes mellitus
At least 3 sites with PD ≥ 5 mm and/or CAL ≥ 4 mm and BOP
Brazil; 23 HIV seropositive patients of whom 13 had periodontitis and 10 were periodontally healthy; 31 HIV seronegative patients of whom 17 had periodontitis and 14 were periodontally healthy
≥ 10% of teeth with probing depth and/or clinical attachment loss ≥ 5 mm, or ≥ 15% of teeth with probing depth and/or clinical attachment loss ≥ 4 mm, and > 10% of sites with bleeding on probing
Brazil, 225 patients-56 periodontally healthy and 169 chronic periodontitis patients
Plaque index/gingival index/Community Periodontal Index of treatment needs
Saudi Arabia; 75 dyspeptic patients and 60 healthy controls
Non-significant
Non-significant
As discussed in the previous sections, it is clear that H. pylori may be detected in dental plaque. Although the organism is microaerophilic, it has been reported that in the oral cavity, it prefers the supragingival plaque[35,41,75]. However, a few investigators have reported an equal presence of H. pylori in supra-gingival and sub-gingival plaque samples[53,76]. Supra- and sub-gingival plaque represent two different microenvironments that differ in their pH, nutrient supply, oxygen availability, and host defense mechanisms[77]. Subgingival plaque is generally present in periodontal disease where tissue destruction results in progressive deepening of the periodontal pockets. The transformation from supra-gingival to sub-gingival environment and from health to disease is associated with a change in the resident microbial flora[57]. Because dental plaque is a biofilm in which several different bacterial species co-exist through specific interactions between different species, survival of H. pylori in dental plaque depends on its ability to interact with other bacterial species. Studies have shown that H. pylori can selectively adhere to certain bacteria, such as Fusobacterium species (Fusobacterium nucleatum)[52,78], Porphyromonas gingivalis[52], and Bacteroides forsythus[35]. Because the numbers of these bacterial species are increased in periodontitis patients, it is more likely that dental plaque in periodontitis patients may harbor H. pylori by interacting with these bacterial species.
EFFECTS OF ANTI-H. PYLORI THERAPY ON H. PYLORI IN DENTAL PLAQUE
Table 4 shows the studies that evaluated the effects of systemic H. pylori eradication therapy on oral H. pylori. The majority of these studies reported that systemic H. pylori eradication therapy alone (i.e., in the absence of any form of periodontal therapy), although successful in managing the gastric infection, had very little effect on oral H. pylori[46,79]. Although Gebara et al[80] reported an increase in the prevalence of H. pylori in dental plaque in their patients after one week of triple therapy, Bago et al[81] reported that one week of triple therapy resulted in complete eradication of oral H. pylori in all 56 periodontitis patients who had H. pylori-associated gastric disease.
Table 4 Studies evaluating the effects of systemic Helicobacter pylori eradication therapy on oral Helicobacter pylori.
Ref.
Sample population and sample size
Prevalence of H. pylori in dental plaque
Type of anti-H. pylori therapy
Prevalence of H. pylori in dental plaque after anti-H. pylori therapy
China; 80 patients with H. pylori infection-37 treated with anti-H. pylori therapy (gp A) and 43 treated with anti-H. pylori therapy and periodontal therapy (gp B)
82.3% in dental plaque and 51.1% in saliva
Gp A-2 wk proton pump inhibitor or triple therapy; gp B-2 wk triple therapy and initial periodontal therapy (oral hygiene education and scaling)
After 4 wk-29.7% (n = 11) in gp A and 4.7% (n = 2) in gp B; after 1 yr-43.2% (n = 16) in gp A and 18.6% (n = 8) in gp B
Eradication rate of gastric H. pylori After 4 wk-73% (27/37) in gp A and 81.4% (35/43) in gp B After 1 yr-32.4% (11/37) in gp A and 62.8% (27/43) in gp B
Serbia; 44 patients-21 patients positive for H. pylori in subgingival dental plaque and gastric mucosa (G+O+t) and 23 patients who were positive for H. pylori only in gastric mucosa (G+O-t)- all 44 received only anti-H. pylori (triple) therapy
47.7%
Triple therapy consisting of amoxicillin 2 g/d, clarithromycin 1 g/d, and pantoprazole 80 mg/d for 7 d
In G+O+t-66.7% (14/21)
In the G+O+t group, only 47.6% (10/21) showed eradication of gastric H. pylori compared with 87.4% (20/23) in G+O-t
Overall-43.1% (n = 28), 73.7% (28/38) among H. pylori-positive patients
Colloidal bismuth subcitrate 1 g, amoxicillin 500 mg, and metronidazole 250 mg four times daily for 2 wk or cimetidine 200 mg, amoxicillin 500 mg, and metronidazole 250 mg 4 times a day for 2 wk
92.9% (26/28)
H. pylori eradicated from 84.2% (n = 32/38) H. pylori infected individuals
Pakistan; 82 patients positive for H. pylori in dental plaque-27 received only anti-H. pylori therapy (gp 1); 25 received anti-H. pylori therapy+periodontal therapy (gp 2); 30 received only periodontal therapy (gp 3)
100%
Gp 1-twice daily omeprazole 20 mg, clarithromycin 500 mg and metronidazole 400 mg; gp 2-triple therapy and dental scaling and chlorhexidine mouthwashes twice daily for 7 d; gp 3-only dental treatment
100% in gp 1; 16% in gp 2 (4/25); 10% in gp 3 (3/30)
Japan; 47 patients with chronic gastritis or peptic ulcer-48.9% (n = 23) were positive for oral H. pylori and 38.3% (n = 18) had H. pylori in plaque
48.9% (n = 23) were positive for oral H. pylori and 38.3% (n = 18) had H. pylori in plaque
Lansoprazole 30 mg/d, metronidazole 750 mg/d, and clarithromycin 400 mg/d for 2 wk
Oral prevalence at 4 wk-34% (16/47)
At 4 wk-91.6% (22/24) of subjects negative for oral H. pylori were successfully eradicated of H. pylori infection compared to 52.2% (12/23) in oral H. pylori-positive patients. At 2 years, 95.8% (23/24) of subjects negative for oral H. pylori were successfully eradicated of H. pylori infection compared with 69.5% (16/23) in oral H. pylori-positive patients
The systemic H. pylori eradication therapy in these studies usually included two antibiotics and a proton pump inhibitor administered orally. Because microorganisms in the dental plaque are afforded greater protection from systemically administered anti-microbial agents, it may be assumed that systemic H. pylori eradication therapy has little impact on oral H. pylori, hence the observed failure of these therapeutic regimens to eradicate oral H. pylori.
IMPACT OF PERIODONTAL THERAPY ON H. PYLORI INFECTION
Studies that evaluated the effect of periodontal therapy on H. pylori infection are shown in Table 5. Among these, two studies[73,82] evaluated the effect of periodontal therapy on oral H. pylori. While Sambashivaiah et al[73] evaluated the effect of non-surgical therapy on oral H. pylori in patients with and without type II diabetes mellitus, Butt et al[82] compared the effects of triple therapy and periodontal therapy alone and in combination in 82 patients who were positive for H. pylori in dental plaque. They reported that the greatest reduction in plaque H. pylori was in the group of patients who received only periodontal therapy, followed by those who received combination therapy, while H. pylori persisted in dental plaque of all of the patients who received only triple therapy. Jia et al[83] evaluated the effect of periodontal therapy on prevalence of H. pylori in the stomach of dyspeptic patients in whom H. pylori was eradicated from the stomach by systemic H. pylori eradication therapy prior to periodontal intervention. They reported that 6 mo after periodontal therapy, the prevalence of H. pylori in the gastric mucosa was significantly lower among patients who received periodontal therapy compared with controls who did not receive any form of periodontal therapy. However, in this particular study, the authors did not evaluate the presence of H. pylori in the dental plaque of the study participants at any time point.
Table 5 Studies evaluating the effect of periodontal therapy on oral and gastric Helicobacter pylori.
Ref.
Sample population and sample size
Prevalence of H. pylori in dental plaque
Details of periodontal therapy
Prevalence of H. pylori in dental plaque after periodontal therapy
China; 80 patients with H. pylori infection-37 treated with anti-H. pylori therapy (gp A) and 43 treated with anti-H. pylori therapy and periodontal therapy (gp B)
82.3% in dental plaque and 51.1% in saliva
Gp A-2 wk proton pump inhibitor or triple therapy; gp B-2 wk triple therapy and initial periodontal therapy (oral hygiene education and scaling)
After 4 wk, 29.7% (n = 11) in gp A and 4.7% (n = 2) in gp B; after 1 yr, 43.2% (n = 16) in gp A and 18.6% (n = 8) in gp B
Eradication rate of gastric H. pylori After 4 wk, 73% (27/37) in gp A and 81.4% (35/43) in gp B, after 1 year, 32.4% (11/37) in gp A and 62.8% (27/43) in gp B
India; 36 patients in 3 groups-group I, healthy subjects, group II, chronic periodontitis patients, group III, chronic periodontitis patients with type II diabetes mellitus
Overall-66.7% (n = 24); among group I-41.7% (n = 5), group II-75% (n = 9), group III-83.3% (n = 10)
Group II and III patients received full mouth scaling and root planning
Serbia; 43 patients positive for H. pylori in sub gingival dental plaque and gastric mucosa-21 received only anti-H. pylori (triple) therapy (G+O+t); 22 received anti-H. pylori (triple) therapy)+periodontal therapy (G+O+tp)
100%
Triple therapy consisting of amoxicilin 2 g/d, clarithromycin 1 g/d, and pantoprazole 80 mg/d for 7 d. Periodontal therapy included oral hygiene orientation, plaque and calculus removal with an ultrasonic device, scaling, and root planing, as well as irrigation of periodontal pockets with 0.12% chlorhexidine-gluconate performed during triple therapy, in one sitting
In G+O+t-66.7% (14/21); in G+O+tp-27.3% (6/22)
In the G+O+tp group, 77.3% (17/ 22) showed eradication of gastric H. pylori compared with 47.6% (10/21) in G+O+t
China; 107 dyspeptic patients in whom H. pylori was eradicated from the gastric mucosa-56 received dental plaque control (test) and 51 did not (control)
Not evaluated
Full-mouth scaling, root planning and polishing, and dental plaque control instructions by dentist
Not evaluated
Prevalence of H. pylori in gastric mucosa was 19.64% (11/56) in test group and 84.31% (43/51) in control group
Pakistan; 82 patients positive for H. pylori in dental plaque-27 received only anti-H. pylori therapy (gp 1); 25 received anti-H. pylori therapy+periodontal therapy (gp 2); 30 received only periodontal therapy (gp 3)
100%
Gp 1-twice daily omeprazole 20 mg, clarithromycin 500 mg and metronidazole 400 mg; gp 2-triple therapy and dental scaling and chlorhexidine mouthwashes twice daily for 7 d; gp 3-only dental treatment
100% in gp 1; 16% in gp 2 (4/25); 10% in gp 3 (3/30)
Not evaluated
Two of the five studies listed in Table 5 evaluated the effects of periodontal therapy on oral and gastric H. pylori[46,72]. Gao et al[46] reported that among the 43 H. pylori-positive patients who received both anti-H. pylori therapy and periodontal therapy, the gastric eradication rates at 4 wk and 1 year after intervention were 81.4% (n = 35/43) and 62.8% (n = 27/43), respectively, while the eradication rates over the same time periods among the 37 H. pylori-positive patients who received only anti-H. pylori therapy were 73% (n = 27/37) and 32.4% (n = 11/37), respectively. They also reported that the detection rates of H. pylori in dental plaque of patients who received both forms of therapy at 4 wk and 1 year after intervention were 4.7% (n = 2/43) and 18.6% (n = 8/43), respectively, while the corresponding rates for the patients who received only anti-H. pylori therapy were 29.7% (n = 11/37) and 43.2% (n = 16/37), respectively. In another study by Zaric et al[72], 43 patients positive for H. pylori in both subgingival plaque and gastric mucosa were categorized into two groups in which 21 patients received only anti-H. pylori therapy and 22 received anti-H. pylori therapy along with periodontal therapy. Three months after treatment completion, 77.3% (n = 17/22) of the patients who received both anti-H. pylori therapy and periodontal therapy showed gastric eradication compared with only 47.6% (n = 10/21) of the patients who received only anti-H. pylori therapy. Among the 22 patients who received both anti-H. pylori therapy and periodontal therapy, H. pylori was detected in dental plaque of only six (27.3%) patients 3 mo after completion of treatment, whereas the microorganism was detected in 66.7% (n = 14) of the 21 patients who received only anti-H. pylori therapy. The authors also reported that eradication in the stomach coincided with eradication in the oral cavity (i.e., all 16 of the individuals who received both forms of therapy and showed eradication of oral H. pylori also showed eradication of gastric H. pylori). Five of the participants in this group who were positive for oral samples were also positive for gastric H. pylori.
The periodontal therapy provided to the patients in these studies consisted of non-surgical periodontal therapy, in which the microbial deposits on the surfaces of the teeth are professionally removed by the dentists, along with other plaque control measures, such as use of mouthwashes and patient education in plaque control. This phase of treatment is referred to as the Etiotropic phase and is considered to be very important because the microbial etiological factors of periodontal disease are removed in this phase. As mentioned previously, because of its biofilm properties, dental plaque provides resistance to the resident microflora from systemically administered antimicrobial agents. Thus, the H. pylori present in the dental plaque are seldom affected by systemic H. pylori eradication therapy, as shown in previous studies conducted[39,80]. As a result, the removal of H. pylori in the dental plaque may necessitate periodontal therapy in which all microbial deposits, along with the resident bacteria, including H. pylori, will be eliminated. The initial studies in this regard have shown promising results in the management of both oral and gastric H. pylori.
CONCLUSION
Although H. pylori has long been known to be detected in the oral cavity, the significance of such findings was controversial. If the oral cavity is an important extra-gastric reservoir of H. pylori, then this finding may have major implications because the oral cavity can serve as both a source of re-infection and route of transmission. Because plaque-associated H. pylori would be resistant to systemic H. pylori eradication therapy, it can affect the success rates of the anti-H. pylori therapy. Thus, it is imperative to identify the role of dental plaque, saliva, and periodontal disease in H. pylori infection. Once these factors are clearly understood and whether the oral cavity is a major extra-gastric reservoir of H. pylori is confirmed, then newer treatment modalities, such as periodontal therapy, may be incorporated in the protocol for the management of H. pylori infection. The initial studies on the role of periodontal therapy in the management of H. pylori infection have shown promising results, suggesting that oral H. pylori may play an important role in re-infection of the gastric mucosa. These observations also create new avenues for both future research and more effective management of H. pylori infection.
Footnotes
P- Reviewers: Ananthakrishnan N, Gokul S, Handa O S- Editor: Gou SX L- Editor: A E- Editor: Wang CH
Warren J, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis.Lancet. 1983;1:1273-1275.
[PubMed] [DOI][Cited in This Article: ]
Wang RT, Wang T, Chen K, Wang JY, Zhang JP, Lin SR, Zhu YM, Zhang WM, Cao YX, Zhu CW. Helicobacter pylori infection and gastric cancer: evidence from a retrospective cohort study and nested case-control study in China.World J Gastroenterol. 2002;8:1103-1107.
[PubMed] [DOI][Cited in This Article: ]
Schistosomes , liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994.IARC Monogr Eval Carcinog Risks Hum. 1994;61:1-241.
[PubMed] [DOI][Cited in This Article: ]
Qu XH, Huang XL, Xiong P, Zhu CY, Huang YL, Lu LG, Sun X, Rong L, Zhong L, Sun DY. Does Helicobacter pylori infection play a role in iron deficiency anemia? A meta-analysis.World J Gastroenterol. 2010;16:886-896.
[PubMed] [DOI][Cited in This Article: ]
Farsak B, Yildirir A, Akyön Y, Pinar A, Oç M, Böke E, Kes S, Tokgözoğlu L. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR.J Clin Microbiol. 2000;38:4408-4411.
[PubMed] [DOI][Cited in This Article: ]
Janssen MJ, Van Oijen AH, Verbeek AL, Jansen JB, De Boer WA. A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole.Aliment Pharmacol Ther. 2001;15:613-624.
[PubMed] [DOI][Cited in This Article: ][Cited by in Crossref: 58][Cited by in F6Publishing: 66][Article Influence: 2.9][Reference Citation Analysis (0)]
Takeuchi T, Umegaki E, Takeuchi N, Yoda Y, Kojima Y, Tokioka S, Higuchi K. Strategies for peptic ulcer healing after 1 week proton pump inhibitor-based triple Helicobacter pylori eradication therapy in Japanese patients: differences of gastric ulcers and duodenal ulcers.J Clin Biochem Nutr. 2012;51:189-195.
[PubMed] [DOI][Cited in This Article: ][Cited by in Crossref: 8][Cited by in F6Publishing: 10][Article Influence: 0.8][Reference Citation Analysis (0)]
Nelson DB, Muscarella LF. Current issues in endoscope reprocessing and infection control during gastrointestinal endoscopy.World J Gastroenterol. 2006;12:3953-3964.
[PubMed] [DOI][Cited in This Article: ]
van Duynhoven YT, de Jonge R. Transmission of Helicobacter pylori: a role for food?Bull World Health Organ. 2001;79:455-460.
[PubMed] [DOI][Cited in This Article: ]
Chen TS. Is the coccoid form of Helicobacter pylori viable and transmissible?J Chin Med Assoc. 2004;67:547-548.
[PubMed] [DOI][Cited in This Article: ]
Dubois A, Fiala N, Heman-Ackah LM, Drazek ES, Tarnawski A, Fishbein WN, Perez-Perez GI, Blaser MJ. Natural gastric infection with Helicobacter pylori in monkeys: a model for spiral bacteria infection in humans.Gastroenterology. 1994;106:1405-1417.
[PubMed] [DOI][Cited in This Article: ]
Fox JG, Batchelder M, Marini R, Yan L, Handt L, Li X, Shames B, Hayward A, Campbell J, Murphy JC. Helicobacter pylori-induced gastritis in the domestic cat.Infect Immun. 1995;63:2674-2681.
[PubMed] [DOI][Cited in This Article: ]
Hwang CY, Han HR, Youn HY. Prevalence and clinical characterization of gastric Helicobacter species infection of dogs and cats in Korea.J Vet Sci. 2002;3:123-133.
[PubMed] [DOI][Cited in This Article: ]
Krajden S, Fuksa M, Anderson J, Kempston J, Boccia A, Petrea C, Babida C, Karmali M, Penner JL. Examination of human stomach biopsies, saliva, and dental plaque for Campylobacter pylori.J Clin Microbiol. 1989;27:1397-1398.
[PubMed] [DOI][Cited in This Article: ]
Majmudar P, Shah SM, Dhunjibhoy KR, Desai HG. Isolation of Helicobacter pylori from dental plaques in healthy volunteers.Indian J Gastroenterol. 1990;9:271-272.
[PubMed] [DOI][Cited in This Article: ]
Dowsett SA, Archila L, Segreto VA, Gonzalez CR, Silva A, Vastola KA, Bartizek RD, Kowolik MJ. Helicobacter pylori infection in indigenous families of Central America: serostatus and oral and fingernail carriage.J Clin Microbiol. 1999;37:2456-2460.
[PubMed] [DOI][Cited in This Article: ]
Patchett S, Beattie S, Leen E, Keane C, O’Morain C. Helicobacter pylori and duodenal ulcer recurrence.Am J Gastroenterol. 1992;87:24-27.
[PubMed] [DOI][Cited in This Article: ]
Chitsazi MT, Fattahi E, Farahani RM, Fattahi S. Helicobacter pylori in the dental plaque: is it of diagnostic value for gastric infection?Med Oral Patol Oral Cir Bucal. 2006;11:E325-E328.
[PubMed] [DOI][Cited in This Article: ]
Czesnikiewicz-Guzik M, Bielanski W, Guzik TJ, Loster B, Konturek SJ. Helicobacter pylori in the oral cavity and its implications for gastric infection, periodontal health, immunology and dyspepsia.J Physiol Pharmacol. 2005;56 Suppl 6:77-89.
[PubMed] [DOI][Cited in This Article: ]
Cześnikiewicz-Guzik M, Karczewska E, Bielański W, Guzik TJ, Kapera P, Targosz A, Konturek SJ, Loster B. Association of the presence of Helicobacter pylori in the oral cavity and in the stomach.J Physiol Pharmacol. 2004;55 Suppl 2:105-115.
[PubMed] [DOI][Cited in This Article: ]
Loster BW, Czesnikiewicz-Guzik M, Bielanski W, Karczewska E, Loster JE, Kalukin J, Guzik TJ, Majewski S, Konturek SJ. Prevalence and characterization of Helicobacter pylori (H. pylori) infection and colonization in dentists.J Physiol Pharmacol. 2009;60 Suppl 8:13-18.
[PubMed] [DOI][Cited in This Article: ]
Marsh PD. Microbial ecology of dental plaque and its significance in health and disease.Adv Dent Res. 1994;8:263-271.
[PubMed] [DOI][Cited in This Article: ]
Song Q, Lange T, Spahr A, Adler G, Bode G. Characteristic distribution pattern of Helicobacter pylori in dental plaque and saliva detected with nested PCR.J Med Microbiol. 2000;49:349-353.
[PubMed] [DOI][Cited in This Article: ]
Morales-Espinosa R, Fernandez-Presas A, Gonzalez-Valencia G, Flores-Hernandez S, Delgado-Sapien G, Mendez-Sanchez JL, Sanchez-Quezada E, Muñoz-Pérez L, Leon-Aguilar R, Hernandez-Guerrero J. Helicobacter pylori in the oral cavity is associated with gastroesophageal disease.Oral Microbiol Immunol. 2009;24:464-468.
[PubMed] [DOI][Cited in This Article: ][Cited by in Crossref: 22][Cited by in F6Publishing: 23][Article Influence: 1.6][Reference Citation Analysis (0)]
Al Asqah M, Al Hamoudi N, Anil S, Al Jebreen A, Al-Hamoudi WK. Is the presence of Helicobacter pylori in dental plaque of patients with chronic periodontitis a risk factor for gastric infection?Can J Gastroenterol. 2009;23:177-179.
[PubMed] [DOI][Cited in This Article: ]
Bali D, Rosamma J, Bali A. The Association of Dental Plaque And Helicobacter Pylori Infection In Dyspeptic Patients Undergoing Endoscopy.J Clin Diagn Res. 2010;4:3614-3621.
[PubMed] [DOI][Cited in This Article: ]
Butt AK, Khan AA, Khan AA, Izhar M, Alam A, Shah SW, Shafqat F. Correlation of Helicobacter pylori in dental plaque and gastric mucosa of dyspeptic patients.J Pak Med Assoc. 2002;52:196-200.
[PubMed] [DOI][Cited in This Article: ]
Avcu N, Avcu F, Beyan C, Ural AU, Kaptan K, Ozyurt M, Nevruz O, Yalçin A. The relationship between gastric-oral Helicobacter pylori and oral hygiene in patients with vitamin B12-deficiency anemia.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;92:166-169.
[PubMed] [DOI][Cited in This Article: ]
Suk FM, Chen SH, Ho YS, Pan S, Lou HY, Chang CC, Hsieh CR, Cheng YS, Lien GS. It is difficult to eradicate Helicobacter pylori from dental plaque by triple therapy.Zhonghua Yixue Zazhi (Taipei). 2002;65:468-473.
[PubMed] [DOI][Cited in This Article: ]
Berroteran A, Perrone M, Correnti M, Cavazza ME, Tombazzi C, Goncalvez R, Lecuna V. Detection of Helicobacter pylori DNA in the oral cavity and gastroduodenal system of a Venezuelan population.J Med Microbiol. 2002;51:764-770.
[PubMed] [DOI][Cited in This Article: ]
Goosen C, Theron J, Ntsala M, Maree FF, Olckers A, Botha SJ, Lastovica AJ, van der Merwe SW. Evaluation of a novel heminested PCR assay based on the phosphoglucosamine mutase gene for detection of Helicobacter pylori in saliva and dental plaque.J Clin Microbiol. 2002;40:205-209.
[PubMed] [DOI][Cited in This Article: ][Cited by in Crossref: 28][Cited by in F6Publishing: 31][Article Influence: 1.4][Reference Citation Analysis (0)]
Al-Refai AN, Fathalla SE, Nagamani R, Al-Momen S. Incidence of helicobacter pylori in dental plaque of saudi gastritis patients.J Family Community Med. 2002;9:27-36.
[PubMed] [DOI][Cited in This Article: ]
Ozdemir A, Mas MR, Sahin S, Sağlamkaya U, Ateşkan U. Detection of Helicobacter pylori colonization in dental plaques and tongue scrapings of patients with chronic gastritis.Quintessence Int. 2001;32:131-134.
[PubMed] [DOI][Cited in This Article: ]
